ADMINISTRATION SITE NODULE

This adverse event was reported 60 times

ADMINISTRATION SITE NODULE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LIDOCAINE, PRILOCAINE 1 0.0050
1 APOMORPHINE HYDROCHLORIDE 5 0.0030
2 SAFINAMIDE MESYLATE 3 0.0022
3 SOYBEAN OIL 1 0.0015
4 FOSCARBIDOPA/FOSLEVODOPA 9 0.0010
5 HUMAN IMMUNOGLOBULIN G 16 0.0008
6 CABOTEGRAVIR SODIUM 1 0.0006
7 GLUTATHIONE 1 0.0006
8 PEGCETACOPLAN 1 0.0005
9 MINERAL SUNSHIELD UNIVERSAL TINT BROAD SPECTRUM SPF 30 SUNSCREEN 1 0.0005
See all drugs enriched for association with ADMINISTRATION SITE NODULE

ADMINISTRATION SITE NODULE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 16 0.0008
1 Nitrogen Binding Agent [EPC] 1 0.0004
2 Lipid Emulsion [EPC] 1 0.0004
3 Carnitine Analog [EPC] 1 0.0003
4 beta Lactamase Inhibitor [EPC] 1 0.0002
5 Catecholamine [EPC] 8 0.0001
6 Barbiturate [EPC] 1 0.0001
7 GLP-2 Analog [EPC] 1 0.0001
8 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
9 Aromatic Amino Acid Decarboxylation Inhibitor [EPC] 2 0.0001
See all drug classes enriched for association with ADMINISTRATION SITE NODULE